Oramed Pharmaceuticals(FRA) OJU1

Market Cap€178.04M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€4.26

-0.58%

-0.02Today

Oramed Pharmaceuticals Financials at a Glance

Market Cap

€178.04M

Revenue (TTM)

€0.00

Net Income (TTM)

€149.28

EPS (TTM)

€3.53

P/E Ratio

1.21

Dividend

€0.00

Beta (Volatility)

-0.08 (Low)

Dividend

€0.00

Beta (Volatility)

-0.08 (Low)

Price

€4.26

Volume

Open

€4.26

Price

€4.26

Volume

Open

€4.26

Previous Close

€4.28

Daily Range

€4.26 - €4.26

52-Week Range

€1.83 - €4.53

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.08 (Low)

Price

€4.26

Volume

Open

€4.26

Previous Close

€4.28

Daily Range

€4.26 - €4.26

52-Week Range

€1.83 - €4.53

Estimated Earnings Date

N/A

OJU1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oramed Pharmaceuticals

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Nadav Kidron, MBA

Website

www.oramed.com

OJU1 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

72.94%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

82.64%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€178.04M

Shares Outstanding

41.60M

Volume

Avg. Volume

194.439

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Oramed Pharmaceuticals Performance Analysis

Oramed Pharmaceuticals annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 2,571,899	13.7%
2023	2023-12-31	EUR 1,239,460	-51.8%
2024	2024-12-31	EUR 0	N/A
2025	2025-12-31	EUR 1,772,142	N/A

Oramed Pharmaceuticals annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -0.89	36.5%
2023	2023-12-31	EUR 0.13	N/A
2024	2024-12-31	EUR -0.43	N/A
2025	2025-12-31	EUR 1.33	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€0.00

N/A

Gross Profit

-€0.03

+1.0%

Gross Margin

-85.00%

N/A

Market Cap

€178.04M

N/A

Market Cap/Employee

€12.58

N/A

Employees

N/A

Net Income

€67.22

+5.7%

EBITDA

-€2.35

+1.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€13.98

-1.8%

Total Debt

€0.64

+0.8%

Accounts Receivable

N/A

Inventory

€0.00

N/A

Long Term Debt

€0.42

+0.8%

Short Term Debt

€0.22

+1.0%

Return on Assets

64.76%

-4.4%

Return on Invested Capital

39.01%

N/A

Free Cash Flow

-€0.26

+0.1%

Operating Cash Flow

-€0.26

+0.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About OJU1

What is the current price of Oramed Pharmaceuticals?

Oramed Pharmaceuticals is trading at €4.26 per share.

What is the 52-week range for Oramed Pharmaceuticals?

Over the past 52 weeks, Oramed Pharmaceuticals has traded between €1.83 and €4.53.

How much debt does Oramed Pharmaceuticals have?

As of the most recent reporting period, Oramed Pharmaceuticals reported total debt of €641.13K.

How much cash does Oramed Pharmaceuticals have on hand?

Oramed Pharmaceuticals reported €13.33M in cash and cash equivalents in its most recent financial results.

What is Oramed Pharmaceuticals’s dividend yield?

Oramed Pharmaceuticals does not currently have a dividend yield.

Oramed Pharmaceuticals(FRA) OJU1

Oramed Pharmaceuticals Financials at a Glance

OJU1 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Oramed Pharmaceuticals

OJU1 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Oramed Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OJU1

What is the current price of Oramed Pharmaceuticals?

What is the 52-week range for Oramed Pharmaceuticals?

How much debt does Oramed Pharmaceuticals have?

How much cash does Oramed Pharmaceuticals have on hand?

What is Oramed Pharmaceuticals’s dividend yield?

Premium Investing Services